Thomas Först

13.4k total citations · 2 hit papers
228 papers, 7.5k citations indexed

About

Thomas Först is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Thomas Först has authored 228 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 156 papers in Endocrinology, Diabetes and Metabolism, 61 papers in Molecular Biology and 54 papers in Surgery. Recurrent topics in Thomas Först's work include Diabetes Treatment and Management (92 papers), Diabetes Management and Research (84 papers) and Metabolism, Diabetes, and Cancer (50 papers). Thomas Först is often cited by papers focused on Diabetes Treatment and Management (92 papers), Diabetes Management and Research (84 papers) and Metabolism, Diabetes, and Cancer (50 papers). Thomas Först collaborates with scholars based in Germany, United States and Austria. Thomas Först's co-authors include Andreas Pfützner, T. Kunt, G Lübben, C Hohberg, M Hanefeld, Peter Herbert Kann, Matthias Langenfeld, Thomas R. Konrad, Christoph Kapitza and Matthias M. Weber and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Investigation.

In The Last Decade

Thomas Först

216 papers receiving 7.1k citations

Hit Papers

Exenatide once weekly ver... 2012 2026 2016 2021 2012 2014 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
    2012 460 citations Thomas Först et al. profile →
  2. Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
    2014 391 citations Thomas Först et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Thomas Först 4.7k 2.3k 2.2k 1.0k 958 228 7.5k
Daniel Einhorn 5.8k 1.2× 2.0k 0.9× 1.6k 0.8× 823 0.8× 891 0.9× 43 7.4k
David M. Kendall 5.3k 1.1× 2.2k 1.0× 3.0k 1.4× 588 0.6× 985 1.0× 108 7.4k
Andreas Pfützner 3.6k 0.8× 1.5k 0.7× 1.8k 0.8× 1.0k 1.0× 821 0.9× 231 6.5k
Jorge Luiz Gross 5.8k 1.2× 2.3k 1.0× 2.3k 1.0× 1.0k 1.0× 1.5k 1.6× 234 10.5k
Ananda Basu 4.2k 0.9× 1.9k 0.8× 2.7k 1.3× 773 0.8× 1.5k 1.6× 136 7.4k
Guntram Schernthaner 6.2k 1.3× 2.9k 1.3× 2.7k 1.2× 1.3k 1.3× 1.7k 1.8× 227 11.0k
Robert Sherwin 4.1k 0.9× 1.8k 0.8× 1.5k 0.7× 606 0.6× 1.0k 1.1× 44 6.2k
Wayne Huey‐Herng Sheu 3.0k 0.6× 1.8k 0.8× 1.4k 0.6× 1.3k 1.3× 1.3k 1.4× 372 8.1k
Vanita R. Aroda 7.3k 1.5× 3.2k 1.4× 2.1k 1.0× 981 1.0× 1.6k 1.7× 166 10.2k
Muhammad Abdul‐Ghani 4.8k 1.0× 3.2k 1.4× 2.4k 1.1× 899 0.9× 1.6k 1.7× 127 7.5k

Countries citing papers authored by Thomas Först

Since Specialization
Citations

This map shows the geographic impact of Thomas Först's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Först with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Först more than expected).

Fields of papers citing papers by Thomas Först

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Först. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Först. The network helps show where Thomas Först may publish in the future.

Co-authorship network of co-authors of Thomas Först

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Först. A scholar is included among the top collaborators of Thomas Först based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Först. Thomas Först is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mader, Julia K., Delia Waldenmaier, Gerhard Vogt, et al.. (2024). Performance of a Novel Continuous Glucose Monitoring Device in People With Diabetes. Journal of Diabetes Science and Technology. 18(5). 1044–1051. 6 indexed citations
2.
Block, Christophe De, Juan P. Frías, Clare J. Lee, et al.. (2024). Tirzepatide reduces HbA1c and body weight significantly more than placebo or semaglutide irrespective of baseline beta-cell function: post-hoc analysis from SURPASS-1 and SURPASS-2. Diabetologie und Stoffwechsel. 19(S 01). S78–S78. 1 indexed citations
3.
Först, Thomas, Christophe De Block, Stefano Del Prato, et al.. (2024). The role of incretin receptor agonists in the treatment of obesity. Diabetes Obesity and Metabolism. 26(10). 4178–4196. 10 indexed citations
4.
Schütt, Katharina, Thomas Först, Andreas L. Birkenfeld, et al.. (2024). Diabetes Mellitus and the Heart. Experimental and Clinical Endocrinology & Diabetes. 132(2). 64–67.
5.
Geier, Andreas, et al.. (2023). Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug–drug interactions. British Journal of Clinical Pharmacology. 90(4). 942–958. 16 indexed citations
6.
Giorgino, Francesco, Tadej Battelino, Richard M. Bergenstal, et al.. (2023). The Role of Ultra-Rapid-Acting Insulin Analogs in Diabetes: An Expert Consensus. Journal of Diabetes Science and Technology. 19(2). 452–469. 5 indexed citations
7.
8.
Först, Thomas, Pratik Choudhary, Doron Schneider, Bruno Linetzky, & Paolo Pozzilli. (2020). A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes. Diabetes/Metabolism Research and Reviews. 37(6). e3418–e3418. 18 indexed citations
9.
Kropff, Jort, Pratik Choudhary, Sankalpa Neupane, et al.. (2016). Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial. Diabetes Care. 40(1). 63–68. 131 indexed citations
10.
Skrivanek, Zachary, Brenda Gaydos, Jenny Y. Chien, et al.. (2014). Dose‐finding results in an adaptive, seamless, randomized trial of once‐weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD‐5). Diabetes Obesity and Metabolism. 16(8). 748–756. 49 indexed citations
11.
Kapitza, Christoph, et al.. (2013). Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin. Diabetes Obesity and Metabolism. 15(7). 642–649. 161 indexed citations
12.
Först, Thomas, Georg Michelson, Frank Ratter, et al.. (2012). Addition of liraglutide in patients with Type 2 diabetes well controlled on metformin monotherapy improves several markers of vascular function. Diabetic Medicine. 29(9). 1115–1118. 63 indexed citations
13.
Hellhammer, Dirk H., Petra Musholt, A Pfützner, et al.. (2011). Evaluation of Dexterity in Insulin-Treated Patients with Type 1 and Type 2 Diabetes Mellitus. Journal of Diabetes Science and Technology. 5(1). 158–165. 45 indexed citations
14.
Behnke, Thomas, et al.. (2011). Accuracy Evaluation of Five Blood Glucose Monitoring Systems Obtained from the Pharmacy: A European Multicenter Study with 453 Subjects. Diabetes Technology & Therapeutics. 14(4). 330–337. 71 indexed citations
15.
Pfützner, Andreas, Thomas Schöndorf, Diethelm Tschöpe, et al.. (2011). PIOfix-Study: Effects of Pioglitazone/Metformin Fixed Combination in Comparison with a Combination of Metformin with Glimepiride on Diabetic Dyslipidemia. Diabetes Technology & Therapeutics. 13(6). 637–643. 15 indexed citations
16.
Först, Thomas, et al.. (2010). Adding insulin glargine vs. NPH insulin to metformin results in a more efficient postprandial β ‐cell protection in individuals with type 2 diabetes. Diabetes Obesity and Metabolism. 12(5). 437–441. 15 indexed citations
17.
18.
Först, Thomas, Martin Larbig, Michael Safinowski, et al.. (2008). Effect of Insulin Glulisine on Microvascular Blood Flow and Endothelial Function in the Postprandial State. Diabetes Care. 31(5). 1021–1025. 12 indexed citations
19.
Pfützner, Andreas, Nikolaus Marx, G Lübben, et al.. (2005). Improvement of Cardiovascular Risk Markers by Pioglitazone Is Independent From Glycemic Control. Journal of the American College of Cardiology. 45(12). 1925–1931. 233 indexed citations
20.
Först, Thomas, et al.. (1995). Evaluation of neuropathic involvement by fibre type in patients with either insulin-dependent or non-insulin dependent diabetes with and without neurotrophic foot ulceration. 8(5). 292–297. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Einhorn Breakdown of academic impact, for papers by David M. Kendall Breakdown of academic impact, for papers by Andreas Pfützner Breakdown of academic impact, for papers by Jorge Luiz Gross Breakdown of academic impact, for papers by Ananda Basu Breakdown of academic impact, for papers by Guntram Schernthaner Breakdown of academic impact, for papers by Robert Sherwin Breakdown of academic impact, for papers by Wayne Huey‐Herng Sheu Breakdown of academic impact, for papers by Vanita R. Aroda Breakdown of academic impact, for papers by Muhammad Abdul‐Ghani
Rankless by CCL
2026